Alpha Teknova, Inc. (TKNO)
Makes lab chemicals that researchers use to develop drugs and vaccines.
$5.09+0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+20.0%
The outlook
TKNO is trading above both its 50- and 200-day moving averages, sitting roughly two-thirds of the way up its 52-week range. Analyst coverage is light at three firms, but they lean toward "Buy" on average, with a consensus price target about 77% above the current price. The overall sentiment scores as bullish based on recent technical positioning.
What’s behind the score
Analyst consensusBuy — 1.7 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range67% of the way from its 52-week low to high
Price targetAvg target +77% vs current price
Analyst price target
~12-month · 3 analysts$9.00average target+76.8% vs now
Now $5.09
Low $7.00High $12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$272.9M
52-wk high
$6.68
52-wk low
$1.91
50-day avg
$4.90
200-day avg
$3.98
Trailing P/E
—